African Cannabis aims to establish a globally recognised brand in production and export of quality, legally approved dried cannabis flower and cannabis oil products for medical uses.
African Cannabis intends to rapidly take advantage of growing global demand, the growing trend of legalisation across the African continent, and optimal production conditions in Africa.
In participating North American and European markets, the cost to produce medical cannabis is increasing, prompting buyers to seek premium cannabis from other legalized countries.
African Cannabis is the solution for global cannabis markets, being a premium licensed producer and exporter of high-quality medical cannabis, at lower costs.
With near-perfect growing conditions, lower costs of labour and operations, and many more benefits of cultivating cannabis in African countries, African Cannabis is leading the way in elevating Africa as a medical cannabis supplier to the world.
African Cannabis will produce and market dried cannabis flowers and cannabis oils of various tetrahydrocannabinol (THC) and cannabidiol (CBD) contents.
More than 10,000 tons of cannabis are currently produced on the continent each year, according to the UN.
But African governments have not yet followed the trend of legalisation seen in Europe and the Americas, presenting a vast opportunity for developing legal production.
A few countries have begun the process of legalisation and offering licenses, including Lesotho, signalling a wider shift toward more liberal policies.
Several other African governments are considering tapping into what can be a lucrative natural resource for the continent.
The company has already completed its licensing in Lesotho.
African Cannabis aims to establish a globally recognised brand in production and export of quality, legally approved dried cannabis flower and cannabis oil products for medical uses.
African Cannabis is growing rapidly amidst rising global demand, the trend towards legalisation across the African continent as well as optimal production conditions in Africa.
African Cannabis will produce and market dried cannabis flowers and cannabis oils of various tetrahydrocannabinol (THC) and cannabidiol (CBD) contents.
The Market for Medical Cannabis is Growing Rapidly, Driven by Rapid Legalisation and Increasing Medical Applications
Medical Cannabis Market, US$ billion
Cannabis-derived compounds have been demonstrated in pre-clinical and clinical trials to be effective in the treatment of an increasing range of health conditions in humans.
Some of the therapeutic benefits of cannabinoids include Anti- inflammatory, Anti-convulsant, Anti-oxidant, Anti-emetic, Anxiolytic and Anti-psychotic.
As such, Medical Cannabis is now approved for treatment and/or the relief of symptoms in a wide range of conditions.
These include Anxiety/Stress Disorders, Metabolic Disorders/Diabetes, Neuro inflammation, Neurological Disorders/ Epilepsy, Oxidative injury, Nausea and Schizophrenia.
Some of the most important applications are Pain Management (in particular Chronic Pain) and Cancer.
African Cannabis’ Board of Directors and Team is composed of thought-leaders from all over the world, working together from initial phases, to execution, to grow together as a global licenced producer supplying low-cost, high-quality medical cannabis.